Paid Clinical Trials in Valhalla, NY
As of September 2026, 97 paid clinical trials are recruiting in Valhalla, New York. Compensation typically covers time, travel, and study visits, with stipends ranging from modest amounts for short outpatient studies to several thousand dollars for long or inpatient protocols.
Valhalla offers studies at sites including New York Medical College for conditions such as Acute Myeloid Leukemia, ARDS, ARDS (Acute Respiratory Distress Syndrome), Acute Respiratory Distress Syndrome. Both patients with specific conditions and healthy volunteers can qualify. Most trials offer free study-related medical care alongside compensation.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Trials by specialty in Valhalla
Trials by drug in Valhalla
Filter results
Newly added in Valhalla
Posted to ClinicalTrials.gov within the last 60 days — these studies are just starting to recruit.
85 clinical trials
A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity
Phase 2 Study to Assess the Safety and Efficacy of ANG003
A Study of Pembrolizumab (MK-3475) With or Without Intismeran Autogene (V940) in Participants With Non-small Cell Lung Cancer (V940-009/INTerpath-009)
A Prospective Registry Study to Assess Real-world Patient Characteristics, Treatment Patterns, and Longitudinal Outcomes in Patients Receiving Mavacamten and Other Treatments for Symptomatic Obstructive Hypertrophic Cardiomyopathy (Obstructive-HCM)
A Study of Zilovertamab Vedotin (MK-2140) in Combination With Standard of Care in Participants With Relapsed or Refractory Diffuse Large B-Cell Lymphoma (rrDLBCL) (MK-2140-003)
Registry of Patients With Brain Tumors Treated With STaRT (GammaTiles)
JUST BREATHE, Breathing Life Into Innovative Therapies for ARDS (Master Record)
JUST BREATHE, Breathing Life Into Innovative Therapies for ARDS- Cohort C: Bevacizumab
JUST BREATHE, Breathing Life Into Innovative Therapies for ARDS- Cohort B: Paridiprubart
JUST BREATHE, Breathing Life Into Innovative Therapies for ARDS- Cohort A: Vilobelimab
Endurant Stent Graft System vs Excluder Endoprothesis: ADVANCE Trial
Pompe Disease Registry Protocol
Fabry Disease Registry & Pregnancy Sub-registry
Study to evaLuate the effIcacy and Safety of abeLacimab in High-risk Patients With Atrial Fibrillation Who Have Been Deemed Unsuitable for Oral antiCoagulation (LILAC-TIMI 76)
International Collaborative Gaucher Group (ICGG) Gaucher Disease Registry & Pregnancy Sub-registry
Sirolimus Coated BALloon Versus Standard Balloon Angioplasty in The Treatment of Below The Knee Arterial Disease
US National OCS Heart Perfusion (OHP) Registry
A Study to Learn About the Safety of an Expanded Pneumococcal Vaccine in Healthy Infants
A Study of Patritumab Deruxtecan in Pediatric Participants With Relapsed or Refractory Solid Tumors (MK-9999-01C/LIGHTBEAM-U01)
Substudy 01A: Zilovertamab Vedotin in Pediatric and Young Adult Participants With Hematologic Malignancies or Solid Tumors (MK-9999-01A/LIGHTBEAM-U01)
Study of Oral Upadacitinib and Subcutaneous/Intravenous Tocilizumab to Evaluate Change in Disease Activity, Adverse Events and How Drug Moves Through the Body of Pediatric and Adolescent Participants With Active Systemic Juvenile Idiopathic Arthritis.
Safety and Efficacy of APC-0101 in Preterm Infants With Respiratory Distress Syndrome
A Study to Assess Adverse Events, Change in Disease Activity, and How the Drug Moves Through the Body in Children With Juvenile Psoriatic Arthritis (jPsA) Receiving Subcutaneously Injected Risankizumab or Adalimumab
Artificial Intelligence Mapping and Ablation of Non-Pulmonary Vein Electrical Drivers of AF Study
Comparison of Transforming Powder Dressing to NPIAP Recommended Standard of Care Therapies in Stage 2, 3 and 4 Pressure Injuries
Hydration & Female Life Stages
A Study of Ifinatamab Deruxtecan in Pediatric Participants With Relapsed or Refractory Solid Tumors (MK-9999-01D/LIGHTBEAM-U01)
An Adaptive Program of IKT-001 in Pulmonary Arterial Hypertension (PAH)
A Study to Assess Adverse Events and How Intravenous (IV) Pivekimab Sunirine Moves Through the Body in Pediatric Participants With Relapsed or Refractory Acute Myeloid Leukemia (AML)
Beginning Radiation Immediately With GammaTile at GBM Excision Versus Standard of Care
Gene Therapy for CD19-Positive Hematologic Malignancies (SENTRY-CD19)
A Phase 1/2, First-in-Human Study On ODM-212 In Subjects With Selected Advanced Solid Tumours
Enhancing Heart Allograft Function With the OCS Heart System Trial
Acute Partial Thickness Burn Study Comparing Transforming Powder Dressing to Standard of Care Dressing
Active Surveillance, Bleomycin, Etoposide, Carboplatin or Cisplatin in Treating Pediatric and Adult Patients With Germ Cell Tumors
Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small Cell Lung Cancer
Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
Testing the Addition of Total Ablative Therapy to Usual Systemic Therapy Treatment for Limited Metastatic Colorectal Cancer, ERASur Trial
A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations
Top Research Study Locations in Valhalla
Researchers run research studies in Valhalla, NY at 18 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| New York Medical College | Acute Myeloid Leukemia, B Acute Lymphoblastic Leukemia, Mixed Phenotype Acute Leukemia | 41 |
| Westchester Medical Center | ARDS, ARDS (Acute Respiratory Distress Syndrome), Acute Respiratory Distress Syndrome | 31 |
| New York Medical College at Westchester Medical Center | Cystic Fibrosis, Cystic Fibrosis (CF), Cystic Fibrosis Pulmonary Exacerbation | 4 |
| Maria Fareri Children's Hospital | Deep Venous Thrombosis, NAS, Pneumococcal Disease | 3 |
| New York Medical Center | Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, B-cell Lymphoma | 2 |
| New York Medical Center/ Maria Fareri Children's Hospital | Refractory and/or Relapsed Metastatic Solid Tumors, Sarcoma, Solid Tumor, Adult | 2 |
| Boston Childrens Health Physicians | Juvenile Idiopathic Arthritis, Juvenile Psoriatic Arthritis | 2 |
| Anthos Investigative | Atrial Fibrillation (AF) | 1 |
| GSSI Valhalla | Dehydration, Hydration, Menstruation | 1 |
| Gatorade Sports Science Institute | Hydration, Industrial Athlete, Nutrition | 1 |
| Maria Fareri Children's Hospital (West Chester Medical) | Failed or Difficult Intubation, Sequela, Intubation Complication, Intubation; Difficult | 1 |
| Maria Fareri Children's Hospital at Westchester Medical Center | Bronchopulmonary Dysplasia (BPD), Respiratory Distress Syndrome (RDS) | 1 |
| Maria Farreri Children's Hospital | Pre-term Infants, Respiratory Distress Syndrome | 1 |
| New York Medical College, Maria Fareri Children's Hospital | ADA SCID, Leaky SCID, Omenn Syndrome | 1 |
| Omeros Investigational Site | Hematopoietic Stem Cell Transplantation, Thrombotic Microangiopathies | 1 |
| WMCHealth Advanced Physician Services | Obstructive Hypertrophic Cardiomyopathy | 1 |
| Westchester Medical Center / New York Medical College | Aphasia Following Cerebral Infarction, Hemiparesis After Stroke, Stroke | 1 |
| Westchester Medical Center, 100 Woods, Road, Taylor Care Pavillion | Pressure Ulcer, Stage IV, Pressure Ulcers Stage II, Pressure Ulcers Stage III | 1 |
Active & Upcoming Studies in Valhalla (2026)
Recruiting trials in Valhalla grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
Cancer & tumors (31 active studies)
- CD30 CAR T-cells Post AutoHSCT for Poor-risk Hodgkin Lymphoma · Phase 1, Phase 2 · New York Medical College
- A Study to Assess Adverse Events and How Intravenous (IV) Pivekimab Sunirine Moves Through the Body in Pediatric Participants With Relapsed or Refractory Acute Myeloid Leukemia (AML) · Phase 1 · AbbVie
Cardiovascular (10 active studies)
- A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity · Phase 3 · Novo Nordisk A/S
- An Adaptive Program of IKT-001 in Pulmonary Arterial Hypertension (PAH) · Phase 3 · Inhibikase Therapeutics
Neurology & pain (3 active studies)
- Virtual Tai Chi for Chronic Low Back Pain (Spine 2027) · New York Medical College
- Combined Aphasia and Robot-Assisted Arm Treatment for Chronic Stroke Survivors · New York Medical College
Diabetes & metabolic (1 active study)
- A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity · Phase 3 · Novo Nordisk A/S
Common conditions studied in Valhalla
- Acute Myeloid Leukemia (5 active studies)
- ARDS (4 active studies)
- ARDS (Acute Respiratory Distress Syndrome) (4 active studies)
- Acute Respiratory Distress Syndrome (4 active studies)
- Acute Respiratory Distress Syndrome (ARDS) (4 active studies)
- Burkitt Lymphoma (4 active studies)
Leading research sponsors in Valhalla
- New York Medical College
- Children's Oncology Group
- Merck Sharp & Dohme LLC
- National Cancer Institute (NCI)
- PPD Development, LP
Frequently asked questions
How many paid clinical trials are currently recruiting in Valhalla?
There are approximately 97 recruiting clinical trials in Valhalla, New York listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Valhalla pay participants?
Most recruiting trials in Valhalla compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Valhalla?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Valhalla?
The most common conditions under active study in Valhalla include Acute Myeloid Leukemia (5), ARDS (4), ARDS (Acute Respiratory Distress Syndrome) (4), Acute Respiratory Distress Syndrome (4), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Valhalla?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Valhalla on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Valhalla?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Valhalla?
Recruiting research sites in Valhalla include New York Medical College, Westchester Medical Center, New York Medical College at Westchester Medical Center, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Valhalla right now?
The largest active categories in Valhalla are Cancer & tumors (31), Cardiovascular (10), Neurology & pain (3). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.